ProtAb is a company dedicated to eveloping an antibody for the treatment of Rheumatoid Arthritis and other autoimmune diseases such as Crohn's Disease, and has recently raised $4 million.
Name: ProtAb
CEO: Shira Yair
Sector: Biopharma
Medical Field: Autoimmune Diseases
Est.: 2005
Stage: Late stage pre-clinical, after series A funding
Vision: To develop a novel therapeutics for autoimmune diseases, based on the induction of natural anti-inflammatory mechanisms existing in...